Global Gut Microbiota Market to Surpass Market Valuation of USD 3,600.1 Million By 2032 | Elderly Populations is Accounting for More than 54% Revenue Share Says Astute Analytica

The gut microbiota market is seeing strong consumer demand and scientific investment. Products like probiotics and prebiotics are gaining popularity. The focus extends beyond gut health, exploring the microbiome’s role in metabolic diseases, allergies, and even brain function.

New Delhi, Feb. 27, 2024 (GLOBE NEWSWIRE) — The global gut microbiota market, currently valued at approximately US$ 579.5 million in 2023 and is projected to reach over US$ 3,600.1 million by 2032 at a CAGR of 22.50% in the assessment period 2024–2032.

The gut microbiota market is in the process of exploding. With plenty of scientific evidence to back it up, this complex microbial community has a huge effect on human health. The gut itself contains trillions of microorganisms that help with digestion and vitamin synthesis. It also helps develop our immune systems and can even affect the gut-brain axis. And it doesn’t stop there! Research shows that an imbalanced gut microbiota can lead to obesity, inflammatory bowel diseases, metabolic disorders, and maybe even certain cancers.

Get Your Complimentary Sample Report @

People have become more interested in digestive wellness, immune support, and overall health. This interest is only amplified by recent breakthroughs in microbiome sequencing technologies which make for some pretty detailed research. For instance: clinical successes in treating recurrent Clostridioides difficile infections with Fecal Microbiota Transplants (FMT) have opened up a lot of doors and create brand new opportunities for the market. This market should grow even further with the potential of probiotics and prebiotics to promote better gut health as well as their ability to innovate new products. On top of all that, the gut-brain axis’ possible influence on neurological conditions could make way for some serious mental health improvements.

Key Findings in Gut Microbiota Market

Market Forecast (2032) US$ 3,600.1 Million
CAGR 22.50%
Largest Region (2023) North America (41.36%)
By Application Digestive Health (44.10%)
By End Users Elderly (54.25%)
By Type  Probiotics (52.12%)
By Disease Type Irritable Bowel Syndrome (31.15%)
By Distribution Channel Pharmacies and Drugstores (40.04%)
Top Trends
  • Personalized microbiome-based solutions
  • Research into the gut-brain axis
  • Expanding focus beyond digestive health
Top Drivers
  • Scientific discoveries linking microbiome to health
  • Consumer desire for proactive wellness
  • Increased investment in microbiome research
Top Challenges
  • Need for robust clinical evidence
  • Evolving regulatory frameworks
  • Individual microbiome variations complicate treatment

Challenges and Considerations

In order to thrive, players in the gut microbiota market will have to go through some tough obstacles. To sum it up in a sentence: There are different kind of bacteria that enter bodies and each person has their own balance. This is why it’s important to be able to study in great detail how different these variants truly are, using large scale studies like the Human Microbiome Project. It’s difficult to pin down any real causes of diseases when there are millions of tiny little things that could be causing them, so more research needs to go into establishing strong relationships between specific imbalances and illnesses.

Future Outlook

The market is full of surprises. There’s established prebiotic and probiotic manufacturers, pharma companies that are interested in microbiome-based drugs, and startups that work with essential disruptive tech.  Geographically, North America comes first with the biggest market share followed by Europe. The Asia-Pacific region has high growth potential as it increases consumer awareness and research capabilities. Companies need to watch out for regional changes in regulations and preferences to get ahead of their competition.

While there are many possibilities on the scientific side of things, success relies heavily on how regulations change over time as well as ethical concerns around collecting and using personal microbiome data. Public sentiment towards products like these will affect the market too. It’s a double-edged sword: social media trends influence public perception but also give companies an opportunity to blow up. However, despite all this uncertainty, the gut microbiota market is one with a lot of potential. Growth projections show exponential expansion in the coming years and if successful will pave the way for more personalized nutrition options as well as new diagnostics methods and therapeutics to completely reshape healthcare systems.

Gut Microbiota Market Generate More than 44% Revenue from Digestive Health Applications

The digestive health emphasis of the gut microbiota market can be broken down into two parts. The first is the widespread occurrence of digestive issues, and the second are the scientific studies that link these issues to gut microbes in some way or another. About 40% of people worldwide suffer from functional gastrointestinal disorders like IBS, which heavily limits their ability to live a happy life. When you single out IBS alone, 10-15% of adults have it! And that’s not all – there’s more conditions like inflammatory bowel disease (IBD), celiac disease, and gastroesophageal reflux disease (GERD).

That being said, it’s no wonder why consumers are turning to gut microbiota solutions. First off, ongoing research is shining a light on how our imbalanced guts might be contributing to these issues. This leads scientists to believe that they can create innovative treatments by targeting microbial balance directly! Secondly, many people don’t find conventional medicine for IBS and IBD helpful at all. So then why take them? This question has fueled alternative approaches that are holistic and meant to address root causes.

Probiotics and prebiotics are what consumers in the gut microbiota market gets when they look for these alternatives. Probiotics contain beneficial bacteria while prebiotics feed them with fiber – both have potential in boosting digestive health. Specific strains such as Lactobacillus and Bifidobacterium have shown benefits in managing IBS symptoms, improving regularity, and reducing inflammation. On top of this diet also plays a big role – fiber-rich diets in particular seem to promote a diverse and healthy gut microbiome in turn lessening digestive problems overall.

Acquire the Full Report @

Elderly Populations is Accounting for More than 54% Revenue Share of Global Gut Microbiota Market

The elderly are a big consumer group in the gut microbiota market. Many age-related changes to the gut can cause digestive issues, lower immunity and open them up to more chronic illnesses. The problem is further compounded by drugs like antibiotics. Because of this, older individual eed help digesting food and developing their immune system. They might also want ways to manage their health as they age. Today, it has become easy for this population to learn about the connection between gut health and overall health. So, there’s already a demand building up for products that can help with that.

As per Astute Analytica, the market players should focus on probiotics made with many strains of bacteria, prebiotic fiber blends designed for an aging body, and functional foods fortified with well-researched probiotic strains. They should stress benefits like digestive comfort, immune support and proactive health management in their marketing and advertising. That way people know exactly what is good for them. Easy-to-use product formats will be popular too because the elderly tend not to enjoy complicated things. Moreover, if one of these companies were to partner up with healthcare professionals who already serve the elderly, that could do wonders for product credibility and how much it gets out there in the world. A company with a long-term focus that understands these needs has a great chance at success in this market down the road.

Asia Pacific Holds Huge Growth Potential in Global Gut Microbiota Market

Despite North America leading the global market with more than 41% revenue share, Asia Pacific is grabbing attention of industry players. An increasing disposable income in the region has led to a greater willingness to invest in health. As awareness of how gut health affects overall well-being grows, so does demand for microbiome-focused products. However, dietary patterns that resemble Westernization and decreasing activity levels are contributing to more digestive problems and metabolic diseases.  

Today, Chinese companies in the gut microbiota market By-Health and Beijing Bailing Biotechnology Co. lead the microbiota market, while multinational competitors look to expand their reach by establishing a presence across Asia Pacific. Yakult, Kirin Holdings, and Ajinomoto—companies with deep roots in fermented foods—are driving industry innovation in Japan. India’s pharmaceutical sector is helping domestic probiotic and nutraceutical brands grow alongside established medical businesses. In addition to these four major consumers — health-conscious younger urban populations, aging individuals seeking age-related health support, and people with digestive conditions — pharmacies, health food stores, supermarkets and e-commerce platforms are vital distribution channels. China leads the market right now but India, Japan and South Korea all have significant untapped growth potential for these products.

As per Astute Analytica, the competition is about to heat up big time though as multinational brands increasingly recognize the region’s potential for explosive sales growth. They’ll be joining a group of local companies that already do it better than anybody else: The myriad small businesses pushing innovative digestive-health products on social media are finding great success selling directly through e-commerce sites all around Asia Pacific.

Global Gut Microbiota Market Key Players

  • Danone
  • International Flavors & Fragrances Inc.
  • Enterome
  • Ferring Pharmaceuticals
  • Nestlé Health Science
  • Second Genome, Inc.
  • Seed Health
  • Seres Therapeutics
  • Sun Genomics
  • Synlogic, Inc.
  • Viome
  • Yakult Honsha Co., Ltd.
  • Other Prominent Companies

Key Segmentation:

By Product

  • Prebiotics
  • Probiotics
  • Drugs
  • Supplements
  • Others

By Application

  • Digestive Health
  • Immune Health
  • Weight Management
  • Mental Health
  • Cardiovascular Health

By Disease Type

  • Autoimmune Disorder
  • Irritable Bowel Syndrome (IBS)
  • Inflammatory Bowel Disease (IBD)
  • Diabetes
  • Obesity
  • Allergies
  • Others

By End Users

  • Adults
  • Children
  • Elderly

By Distribution Channel

  • Pharmacies and Drugstores
  • Online Retail
  • Health Food Stores
  • Supermarkets and Hypermarkets
  • Specialty Stores

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)
  • South America

Get Our Detailed Methodology @

For further details or to explore our comprehensive industry reports, we invite you to connect with our dedicated team. Please reach out to us at for personalized assistance.

About Astute Analytica

Astute Analytica is a global analytics and advisory company which has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.

Contact us:
Vipin Singh
BSI Business Park, H-15,Sector-63, Noida- 201301- India
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)

CONTACT: Vipin Singh BSI Business Park, H-15,Sector-63, Noida- 201301- India Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) Email: Website:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy